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Abstracts
Gregory L. Moneta, MD, Section EditorAssociation Between Hospital Imaging Use and Venous
Thromboembolism Events Rates Based on Clinical Data
Ju MH, Chung JW, Kinnier CV, et al. Ann Surg 2014;260:558-66.Improved Quality of Life After 1 Year With an Invasive
Versus a Noninvasive Treatment Strategy in Claudicants:
One-Year Results of the Invasive Revascularization or
Not in Intermittent Claudication (IRONIC) Trial
Nordanstig J, Taft C, Hensäter M, et al. Circulation 2014;130:939-47.
Conclusions: An invasive treatment strategy improves intermittent
claudication (IC) distance and health-related quality of life at 1 year in pa-
tients with stable lifestyle-limiting claudication undergoing current medical
management.
Summary: Patients with IC have an increased risk of cardiovascular
events and premature death. In addition, it has been demonstrated that ex-
ercise therapy, particularly supervised exercise therapy, can improve symp-
toms. Therefore, the generally accepted ﬁrst line of treatment for patients
with IC is risk factor modiﬁcation and exercise training. However, super-
vised exercise training, likely the most effective form of exercise therapy, is
not available to many patients. It is also probably only cost effective when
health-related quality of life results are extrapolated beyond the end of
the existing trial data and under the assumption that activity-induced bene-
ﬁts will result in reduction of mortality and cardiovascular events. The
IRONIC trial is a prospective, randomized, controlled study to test the hy-
pothesis that an invasive treatment strategy vs continued noninvasive treat-
ment improves health-related quality of life after 1 year in unselected280patients with IC. Unselected patients with IC after clinical and duplex ultra-
sound assessment, requesting treatment for IC were randomly assigned to
invasive (n ¼ 79) or noninvasive (n ¼ 79) treatment groups. The primary
end point was health-related quality of life after 1 year, assessed with the
Medical Outcomes Study Short Form 36 version 1 and the Vascular Quality
of Life Questionnaire. Secondary end points included walking distance on a
graded treadmill. The SF 36 version 1 physical component summary (P <
.001) and Medical Outcomes Study short Form 36 version 1 physical sub-
scales improved signiﬁcantly more in the invasive vs the noninvasive treat-
ment group. Overall, vascular quality of life questionnaire score (P < .01)
in 3 of 5 domain scores improved signiﬁcantly more in the invasive vs nonin-
vasive treatment group. IC distance improved more in the invasive (+124m)
vs the noninvasive (+50 m) group (P ¼ .003). Change in maximum walking
distance was not signiﬁcantly different between groups. In the invasive
group both endovascular and open procedures were performed with 28 pro-
cedures above the inguinal ligament and 47 below the inguinal ligament. At
1 year, ankle-brachial index and toe pressures were higher in the invasive vs
noninvasive group. Event free survival at 12 months was 77% in invasive vs
88% in the noninvasive group.
Comment: The study results cannot be generalized to patients with
mild or very severe symptoms. In addition, patients in the noninvasive group
received only advised exercise and a structured but not a supervised pro-
gram. Therefore, one may argue that optimal treatment was not provided
to the noninvasive group although perhaps it is real world treatment. In
addition, the number of patients was too small to perform subgroup analysis
on the effect of open vs endovascular treatments and above and below the
inguinal ligament treatments on health quality of life parameters. However
while it is unclear as to the magnitude of beneﬁt with the invasive treatment
strategy, it does not appear that the patients were harmed to a signiﬁcant
extent, at least in this study out to 1 year.The Impact of Acute Renal Failure on Early and Late
Outcomes After Thoracic Aortic Endovascular Repair
Drews JD, Patel HJ, Williams DM, et al. Ann Thorac Surg 2014;97:2027-33.
Conclusions: Acute kidney injury (AKI) is an important risk factor for
both early and late mortality following thoracic aortic endovascular repair
(TEVAR).
Summary: Acute kidney injury (AKI) is a well-known and impor-
tant source of morbidity after thoracic aortic surgery. Most of the debate
however has been derived from open thoracic aortic repair, and there is
limited and conﬂicting data on the frequency of AKI following TEVAR.
The authors note that a recently popularized concensus criteria termed
RIFLE (Risk-injury, failure, loss, end-stage) is a consistent standard by
which to evaluate perioperative renal insufﬁciency (Bellomo R et al,
Intensive Care Med 2007; 33:409-13). The purpose of this study there-
fore was to review the incidence and risk factors that impact AKI occur-
ring after TEVAR over a 20-year period. There were 350 patients
without prior dialysis requirement who underwent TEVAR (1993 to
2013). Mean age was 68.7 years (54% male). The mean preoperative
glomerular ﬁltration rate was 76.5 6 37.6 mL/min, with 39 patients
(11.7%) in chronic kidney disease stage 3 or 4. TEVAR was performed
for rupture in 20.6%. Mean contrast volume administered was 95.7 6
52.9 ml. 4.9% of patients (n ¼ 17) had early mortality. AKI deﬁned as
RIFLE classes risk, injury or failure was seen in 59 (17%) patients (risk
¼ 36, injury ¼ 14, failure ¼ 9). Independent predictors of AKI included
history of a saccular aneurysm, presentation with rupture, or need for
arch repair or red blood cell transfusion (all P < .05). Only two patients
(0.6%) required postoperative dialysis, and none required permanent
dialysis. Ten-year freedom from dialysis was 97.7%. Development of
AKI predicted early mortality (P < .001, odds ratio 9.8). Ten-year sur-
vival was 38.1%. Both injury and failure AKI RIFLE classes indepen-
dently predicted late mortality (P < .05). Length of stay was markedly
increased with occurrence of AKI (mean, 16.8 6 15.5 days vs no AKI,
6.6 6 6.0 days; P < .001). Occurrence of renal failure was also indepen-
dently associated with an increased risk of late mortality and when strat-
iﬁed by class of AKI both the injury and the failure stages independently
predicted late mortality (injury odds ratio, 4.0, P < .001; failure odds ra-
tio, 2.8; P ¼ .039).Conclusions: Venous thromboembolism (VTE) rates when exam-
ined with clinically ascertained outcomes and detailed risk adjustment reﬂect
hospital imaging rates and therefore perhaps are more of an indicator of vigi-
lant high-quality care and not poor performance.
Summary: The Centers for Medicare & Medicaid Services (CMS)
have declared VTE a “never event” that is not additionally reimbursed
following certain operations. VTE performance may also be eventually
tied to ﬁnancial penalties through the 2015 CMS Hospital Value-based Pur-
chasing program. However, the validity of VTE as a quality and safety indi-
cator has been questioned. There’s a real possibility of a co-called
surveillance bias or “the more you look, the more you ﬁnd”. It may be
that hospitals that are more vigilant and look more frequently for VTE
ﬁnd more VTE, and therefore are potentially penalized for having high
VTE rates. Using Medicare administrative claims data limited to patients
$65 years of age or older, the authors previously found evidence to support
this “the more you look, the more your ﬁnd” phenomenon (Bilimoria KY et
al, JAMA 2013;310:1482-9). However, such data was limited to the inpa-
tient period only and many VTE events may occur following hospitalization.
To address these limitations and to encompass a wider variety of patients,
the authors used data from the American College of Surgeons National Sur-
gical Quality Improvement Project (NSQIP) to further investigate the
“more you look, the more you ﬁnd” phenomenon with respect to VTE.
Data from 208 hospitals (2009 to 2010) were used for analysis. Hospitals
were divided into quartiles according to VTE imaging use rates (Medicare
claims). Observed and risk-adjusted postoperative VTE rates (regression
models using the NSQIP data) were examined across VTE imaging use
rate quartiles. Multivariable linear regression models were developed to
assess the impact of hospital characteristics (American Hospital Association)
and hospital imaging use rates on VTE event rates. The mean risk-adjusted
VTE event rates at 30 days after surgery increased across VTE imaging use
rate quartiles: 1.13% in the lowest quartile to 1.92% in the highest quartile
(P < .001). The trend was statistically signiﬁcant and remained when exam-
ining only the inpatient period. Hospital VTE imaging use rate was the
dominant driver of reported VTE event rates (P < .001). No other hospital
characteristics had signiﬁcant associations.
Comment: The data further cast doubt on the use of VTE rates as a
measure of hospital quality and as a valid patient safety indicator. Use of
VTE rates in pay-for-performance may have the unintended consequence
of decreasing VTE imaging rates and subsequent decreased treatment of
VTE because it is not discovered and as a consequence, worse patient
outcomes.
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Volume 61, Number 1 Abstracts 281Comment: The data once again emphasized that AKI following
endovascular aortic repair is an infrequent but morbid complication. For
both open and endovascular repair of the abdominal and thoracic aorta,
acute kidney injury portends a worse short and long-term outcome even
if the patient does not become dialysis dependent.Safety and Efﬁcacy of a Potential Treatment Algorithm by
Using Manual Compression Repair and Ultrasound-Guided
Thrombin Injection for the Management of Iatrogenic
Femoral Artery Pseudoaneurysm in a Large Patient Cohort
Dzijan-Horn M, Langwieser N, Groha P, et al. Circ Cardiovasc Interv
2014;7:207-15.
Conclusions: A treatment algorithm incorporating both manual
compression repair and ultrasound-guided thrombin injection for manage-
ment of iatrogenic femoral artery pseudoaneurysm is both efﬁcacious and
safe.
Summary: When comparing ultrasound-guided manual compression
(USGC) and ultrasound-guided thrombin injection (UGTI), success of
USGC ranges between 71% and 99% but has disadvantages that include
less effectiveness in patients receiving anticoagulation, potentially long pro-
cedure times, and both patient and operator discomfort during compres-
sion. UGTI has higher success rates between 91% and 100% with a low
complication rate, but is an off-label use of thrombin. The authors devel-
oped at their institution in 2007 a treatment algorithm based on morpho-
logic properties of the pseudoaneurysm that they used to guide the use of
USGC or UGTI. In this paper they evaluate the safety and effectiveness
of their algorithm. The algorithm begins with ultrasound imaging of the
pseudoaneurysm. Pseudoaneurysms without a clearly deﬁnable neck and
those directly adjacent to vessels and pseudoaneurysms with a concomitant
arteriovenous ﬁstula were initially referred to USGC. Others were treated
with UGTI. Anticoagulation therapy was not halted routinely before treat-
ment and distal pulses were monitored before and after pseudoaneurysm
treatment. Between January 2007 and January 2011 a total of 432 pseudoa-
neurysms were diagnosed in 29,091 consecutive patients, (1.49%) of those
patients undergoing femoral artery catheterization. Closure devices were
not used. Based on the treatment algorithm there were 145 pseudoaneur-
ysms treated with USGC (34%) and 287 (66%) treated with UTGI.
Follow-up duplex scans were performed within 12 to 14 hours after
USGC only and within 4 to 6 hours after UGTI or by the next morning
and were available for 428 patients (99.1%). The overall success rate of
the institutional algorithm was 97.2% which was achieved by 178 manual
compressions treatments and 357 UGTI procedures, respectively. There
were procedural complications in ﬁve cases (1.4%) after UGTI and three
cases (1.7%) after USGC. The treatment algorithm was not successful in
12 patients; two pseudoaneurysms (0.5%) were subsequently successfully
excluded by implantation of a covered stent, and 10 patients required
surgical intervention (2.3%) which was associated with a complication rate
of 30%.
Comment: Both USGC and UGTI are now standard therapies for
femoral artery iatrogenic pseudoaneurysm. UGTI is preferred by most as
it is quicker, probably more effective, and involves less patient and oper-
ator discomfort. The most feared complication of UGTI is interarterial in-
jection of the thrombin or extension of the clot in the pseudoaneurym into
the femoral artery. The author’s treatment algorithm seeks to minimize
these potential complications. Three patients in this study treated with
UGTI had interarterial thromboembolism, two of which were successfully
treated with heparin only and the third required embolectomy from the
popliteal artery. The author’s treatment algorithm was associated with
an overall high success and low complication rate. It is likely however in
most practices USGC will be used less than described here. The author’s
treatment algorithm is, after all, to a great extent arbitrary. A more aggres-
sive approach with the use of UGTI may be possible with similar compli-
cation rates.Thirty-Year Mortality After Venous Thromboembolism: A
Population-Based Cohort Study
Søgaard KK, Schmidt M, Pedersen L, et al. Circulation 2014;130:829-36.
Conclusions: Patients with Venous Thromboembolism (VTE) are at
increased risk of dying, especially within the ﬁrst year after diagnosis. This
risk however continues after 30 years of follow-up and VTE in these patients
remains an important late cause of death.
Summary: Short-term mortality from VTE has been well studied,
however the magnitude of long-term mortality after VTE is found to vary
substantially between studies. One study reported an 8 year mortality risk
of 12% (Flinterman LE et al, PLoS Med 2012; 9:e1001155). An earlierstudy demonstrated a mortality risk that reached 50% after 8 years of
follow-up (Heit JA et al, Arch Intern Med 1999; 159:445-53). These
studies were, however, of restricted populations and had essentially little in-
formation of long-term mortality comparisons between VTE patients and a
comparison cohort from the general population. One other study has re-
ported a 40% higher mortality in VTE after 10 years compared with the ex-
pected mortality in the general population (Schulman S et al, J Thromb
Haemost 2006; 4:734-42). The authors therefore undertook a nationwide
population based cohort study to examine 30-year VTE mortality with
respect to VTE subtypes, calendar periods of diagnosis and underlying co-
morbidity. They used Danish medical databases with a total of 128,223 pa-
tients with ﬁrst time VTE (1980-2011) and a comparison cohort of
640,760 people from the general population, matched by sex, year of birth,
calendar period and without VTE for comparison. Mortality risk for patients
with deep venous thrombosis (DVT) and pulmonary embolism (PE) were
markedly higher than the comparison cohort during the ﬁrst year, especially
within the ﬁrst 30 days (3.0% and 31% vs 0.4%). Using Cox regression, mor-
tality rate ratios with 95% conﬁdence intervals were estimated. The overall
30-year mortality rate ratio (MRR) was 1.55 (95% conﬁdence interval
[CI], 1.53-1.57) for DVT and 2.77 (95% CI, 2.74-2.81) for PE. Thirty-
day MRR was 5.38 (95% CI, 5.00-5.80) for DVT and 80.87 (95% CI,
76.02-86.02) for PE. Over time, the 30-day MRR was consistently 5 to 6
fold increased for DVT whereas it improved for PE from 138 (95% CI,
125-153) in 1980-1989 to 36.08 (95% CI, 32.65-39.87) in 2000-2011.
The 1- to 10-year and 11- to 30-year MRRs remained 25% to 40% increased
after both DVT and PE but were 3 to 5 fold increased after DVT and 6 to
11 fold increased after PE when VTE was considered the immediate cause
of death.
Comment: This is fascinating data on the long-term mortality risk of
VTE. Vascular surgeons evaluating the effect of long-term VTE have tradi-
tionally focused on the development of chronic venous insufﬁciency. How-
ever like intermittent claudication the risk to the extremity in a patient with
VTE may be dwarfed by the risk to life. The study points out that it is
important to focus on optimizing treatment of VTE in reducing risk factors
for VTE reoccurrence to potentially improve patient mortality over time and
to prevent long-term VTE related death.Silent Cerebral Ischemia After Thoracic Endovascular
Aortic Repair: A Neuroimaging Study
Kahlert P, Eggebrecht H, Jánosi RA, et al. Ann Thorac Surg 2014;98:53-8.
Conclusions: Thoracic endovascular aortic repair (TEVAR) results
in high incidence of new foci of restricted diffusion on cerebral DW-
MRI with a pattern of diffusion deﬁcits suggesting periprocedural
embolization.
Summary: Periprocedural stroke after TEVAR is thought to be
related to emboli which are dislodged during manipulation of guidewires,
catheters, and delivery devices in a diseased aortic arch. It is possible, how-
ever, that in addition to clinically apparent disabling neurologic deﬁcits,
manipulations may also result in clinically silent cerebral embolization.
These silent emboli may be associated with more lingering neurologic
impairment and result in decline of cognitive function and worsening of
dementia during long-term follow-up (Bendszus M et al, Lancet Neurol
2006; 5:364-72). The authors sought to determine the incidence of clin-
ically silent cerebral embolism after TEVAR, postulating that the rate of
clinically silent cerebral ischemia may be higher than that of the clinically
evident cerebral ischemia rates of 2% to 6%. In this study19 patients (13
males and six females) who underwent TEVAR were included into a
descriptive study. Periprocedural apparent and silent cerebral ischemia
were assessed by daily clinical neurologic assessment and serial cerebral
diffusion-weighted magnetic resonance imaging (DW-MRI) at baseline
and 5 days (median interquartile range, 3.5) after the procedure. TEVAR
was successful in all patients without immediately clinically, apparent
neurologic deﬁcits. Post interventional cerebral DW-MRI detected a total
of 29 new foci of restricted diffusion in 12 of 19 TEVAR patients (63%).
Lesions were usually multiple (1 to 6 lesions per patient) and ranged in size
between 15 mm3 to 300 mm3; 16 lesions were found in the left hemi-
sphere, 13 lesions in the right hemisphere. Covering the left subclavian ar-
tery was performed in eight cases, but was not associated with
lateralization of lesions. There were no additional apparent neurologic
events during the in-hospital period.
Comment: Clearly, it is not optimal to be scraping catheters, guide-
wires and sheaths around in the aortic arch. The long-term effects of cere-
bral micro emboli occurring after all types of vascular procedures, including
coronary artery bypass, aortic arch repair, carotid endarterectomy, carotid
artery stenting and now TEVAR still remain to be determined. Neverthe-
less, one has to agree that the DWI lesions seen in this study cannot possibly
be good things.
